Jeffrey C Pearson

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series”.

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa415

N/A

0DataRank · unranked

50 citations

Brandon Dionne, Aaron Richterman, Samuel J. Vidal, Zoe Weiss, Gustavo E. Velásquez +4 more

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy

Kidney International Reports(2020)10.1016/j.ekir.2020.11.025

N/A

0DataRank · unranked

27 citations

Ian A. Strohbehn, Zain Mithani, Jamie S. Hirsch, Rimda Wanchoo, Pranisha Gautam Goyal +8 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Clinical Infectious Diseases(2025)10.1093/cid/ciaf424

N/A

0DataRank · unranked

4 citations

Yngve Falck–Ytter, Lindsey R. Baden, Roger Bedimo, Kelly Cawcutt, Vincent Chi‐Chung Cheng +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf235

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf355

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more

Evaluation of the Safety of Cefazolin Monotherapy in Outpatient Parenteral Antimicrobial Therapy at a Large Academic Medical Center

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf592

N/A

0DataRank · unranked

0 citations

Eric M Gillett, Catherine Franklin, Mark J Estano, Helen S Stevenson, Charles H. DeWan +5 more